345 related articles for article (PubMed ID: 15781834)
21. Vincristine-induced peripheral neuropathy: A mini-review.
Li GZ; Hu YH; Li DY; Zhang Y; Guo HL; Li YM; Chen F; Xu J
Neurotoxicology; 2020 Dec; 81():161-171. PubMed ID: 33053366
[TBL] [Abstract][Full Text] [Related]
22. Vincristine treatment of advanced cancer: a cooperative study of 392 cases.
Holland JF; Scharlau C; Gailani S; Krant MJ; Olson KB; Horton J; Shnider BI; Lynch JJ; Owens A; Carbone PP; Colsky J; Grob D; Miller SP; Hall TC
Cancer Res; 1973 Jun; 33(6):1258-64. PubMed ID: 4352365
[No Abstract] [Full Text] [Related]
23. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study.
Mokhtar GM; Shaaban SY; Elbarbary NS; Fayed WA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):594-600. PubMed ID: 20921909
[TBL] [Abstract][Full Text] [Related]
24. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
[TBL] [Abstract][Full Text] [Related]
25. Neuropathy in multiple myeloma treated with thalidomide: a prospective study.
Plasmati R; Pastorelli F; Cavo M; Petracci E; Zamagni E; Tosi P; Cangini D; Tacchetti P; Salvi F; Bartolomei I; Michelucci R; Tassinari CA
Neurology; 2007 Aug; 69(6):573-81. PubMed ID: 17679676
[TBL] [Abstract][Full Text] [Related]
26. Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain.
Dougherty PM; Cata JP; Burton AW; Vu K; Weng HR
J Pain Symptom Manage; 2007 Feb; 33(2):166-79. PubMed ID: 17280922
[TBL] [Abstract][Full Text] [Related]
27. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
Reinders-Messelink HA; Van Weerden TW; Fock JM; Gidding CE; Vingerhoets HM; Schoemaker MM; Göeken LN; Bökkerink JP; Kamps WA
Eur J Paediatr Neurol; 2000; 4(5):225-33. PubMed ID: 11030069
[TBL] [Abstract][Full Text] [Related]
28. A novel endpoint for the assessment of chemotherapy-induced peripheral neuropathy in rodents: biomechanical properties of peripheral nerve.
Liu CN; Berryman E; Zakur D; Shoieb AM; Pardo ID; Boucher M; Somps CJ; Bagi CM; Cook JC
J Appl Toxicol; 2018 Feb; 38(2):193-200. PubMed ID: 28815646
[TBL] [Abstract][Full Text] [Related]
29. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).
Cil T; Altintas A; Tamam Y; Battaloğlu E; Isikdogan A
J Pediatr Hematol Oncol; 2009 Oct; 31(10):787-9. PubMed ID: 19770686
[TBL] [Abstract][Full Text] [Related]
30. Neurotoxicity of vincristine on the medial olivocochlear bundle.
Riga M; Psarommatis I; Korres S; Varvutsi M; Giotakis I; Apostolopoulos N; Ferekidis E
Int J Pediatr Otorhinolaryngol; 2007 Jan; 71(1):63-9. PubMed ID: 17023056
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy-induced neuropathy: treatment by decompression of peripheral nerves.
Dellon AL; Swier P; Maloney CT; Livengood MS; Werter S
Plast Reconstr Surg; 2004 Aug; 114(2):478-83. PubMed ID: 15277817
[No Abstract] [Full Text] [Related]
32. Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy.
Ozyurek H; Turker H; Akbalik M; Bayrak AO; Ince H; Duru F
Pediatr Hematol Oncol; 2007 Sep; 24(6):447-52. PubMed ID: 17710662
[TBL] [Abstract][Full Text] [Related]
33. Vincristine neuropathy. Clinical and electrophysiological observations.
Casey EB; Jellife AM; Le Quesne PM; Millett YL
Brain; 1973; 96(1):69-86. PubMed ID: 4348690
[No Abstract] [Full Text] [Related]
34. Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-Hodgkin lymphoma: report of the pivotal phase 2 study.
Rodriguez MA; Pytlik R; Kozak T; Chhanabhai M; Gascoyne R; Lu B; Deitcher SR; Winter JN;
Cancer; 2009 Aug; 115(15):3475-82. PubMed ID: 19536896
[TBL] [Abstract][Full Text] [Related]
35. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B;
Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635
[TBL] [Abstract][Full Text] [Related]
36. Bilateral hearing loss during vincristine therapy: a case report.
Kalcioglu MT; Kuku I; Kaya E; Oncel S; Aydogdu I
J Chemother; 2003 Jun; 15(3):290-2. PubMed ID: 12868558
[TBL] [Abstract][Full Text] [Related]
37. Hereditary neuropathy with liability to pressure palsies: description of seven patients without known family history.
Beydoun SR; Sykes SN; Ganguly G; Lee TS
Acta Neurol Scand; 2008 Apr; 117(4):266-72. PubMed ID: 17922888
[TBL] [Abstract][Full Text] [Related]
38. Vincristine-induced neuropathy: Atypical electrophysiological patterns in children.
Courtemanche H; Magot A; Ollivier Y; Rialland F; Leclair-Visonneau L; Fayet G; Camdessanché JP; Péréon Y
Muscle Nerve; 2015 Dec; 52(6):981-5. PubMed ID: 25758843
[TBL] [Abstract][Full Text] [Related]
39. Appropriateness of maximum-dose guidelines for vincristine.
McCune JS; Lindley C
Am J Health Syst Pharm; 1997 Aug; 54(15):1755-8. PubMed ID: 9262750
[No Abstract] [Full Text] [Related]
40. The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice.
Kiguchi N; Maeda T; Kobayashi Y; Kondo T; Ozaki M; Kishioka S
Eur J Pharmacol; 2008 Sep; 592(1-3):87-92. PubMed ID: 18652822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
